Research
Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis
BMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i4482 (Published 06 September 2016) Cite this as: BMJ 2016;354:i4482Related articles
- Research Published: 09 December 2010; BMJ 341 doi:10.1136/bmj.c6624
- Paper Published: 13 September 1997; BMJ 315 doi:10.1136/bmj.315.7109.629
- Research Published: 02 May 2013; BMJ 346 doi:10.1136/bmj.f2573
- Research Published: 26 April 2018; BMJ 361 doi:10.1136/bmj.k1453
- Research Published: 11 August 2020; BMJ 370 doi:10.1136/bmj.m2724
See more
- Stroke: Take test for genetic variant to ensure clopidogrel works for prevention, says NICEBMJ May 19, 2023, 381 p1146; DOI: https://doi.org/10.1136/bmj.p1146
- David Oliver: What the plan for social care omittedBMJ September 10, 2021, 374 n2227; DOI: https://doi.org/10.1136/bmj.n2227
- Stroke: “striking reductions” are seen in number of people with symptoms seeking helpBMJ April 06, 2020, 369 m1406; DOI: https://doi.org/10.1136/bmj.m1406
- NICE recommends implantable monitor to identify atrial fibrillation after strokeBMJ January 14, 2020, 368 m133; DOI: https://doi.org/10.1136/bmj.m133
- Thrombectomy can be considered up to 24 hours after onset of stroke, says NICEBMJ November 23, 2018, 363 k4995; DOI: https://doi.org/10.1136/bmj.k4995
Cited by...
- Risk of atrial fibrillation and association with other diseases: protocol of the derivation and international external validation of a prediction model using nationwide population-based electronic health records
- Progression of stroke risk in patients aged <65 years diagnosed with atrial fibrillation: a cohort study in general practice
- Emulating a target trial to assess effect modification: an application to obesity in the comparative effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation using electronic health records
- Incident cardiovascular, renal, metabolic diseases and death in individuals identified for risk-guided atrial fibrillation screening: a nationwide cohort study
- Resting heart rate and risk of atrial fibrillation in Chinese general population: Kailuan prospective cohort study
- Survival benefits of oral anticoagulation therapy in acute kidney injury patients with atrial fibrillation: a retrospective study from the MIMIC-IV database
- Sex-specific differences in adverse outcome events among patients with atrial fibrillation
- Trends in the pharmacological management of atrial fibrillation in UK general practice 2008-2018
- Association of inverted T wave during atrial fibrillation rhythm with subsequent cardiac events
- NICE atrial fibrillation guideline snubs wearable technology: a missed opportunity?
- Incidence, predictors and mortality risk of new heart failure in patients hospitalised with atrial fibrillation
- Lenient rate control versus strict rate control for atrial fibrillation: a protocol for the Danish Atrial Fibrillation (DanAF) randomised clinical trial
- Anticoagulation in atrial fibrillation
- O-GlcNAcylation, oxidation and CaMKII contribute to atrial fibrillation in type 1 and type 2 diabetes by distinct mechanisms
- Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study
- Modeling Regulatory Network Topology Improves Genome-Wide Analyses of Complex Human Traits
- Using mobile ECG devices to increase detection of atrial fibrillation across a range of settings in south London
- Weight change and the risk of incident atrial fibrillation: a systematic review and meta-analysis
- Association between diabetes mellitus and the risk for major cardiovascular outcomes and all-cause mortality in women compared with men: a meta-analysis of prospective cohort studies
- Thromboembolic and haemorrhagic events in patients with atrial fibrillation: a prospective cohort study in UK primary and secondary care
- Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study
- Protective effects of oral anticoagulants on cerebrovascular diseases and cognitive impairment in patients with atrial fibrillation: protocol for a multicentre, prospective, observational, longitudinal cohort study (Strawberry study)
- Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation: a prospective cohort study in the Netherlands
- Is atrial fibrillation a risk factor for in-hospital cardiac arrest?: a Swedish retrospective cohort study
- Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure
- Atrial fibrillation prevention: an appraisal of current evidence
- Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study
- Association Between Leukocyte Telomere Length and the Risk of Incident Atrial Fibrillation: The Framingham Heart Study
- Integrated management of atrial fibrillation including tailoring of anticoagulation in primary care: study design of the ALL-IN cluster randomised trial
- Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation
- Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents
- Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes
- Associations of Epicardial, Abdominal, and Overall Adiposity With Atrial Fibrillation